Attenuation of Replication-Competent Adenovirus Serotype 26 Vaccines by Vectorization

Replication-competent adenovirus (rcAd)-based vaccine vectors may theoretically provide immunological advantages over replication-incompetent Ad vectors, but they also raise additional potential clinical and regulatory issues. We produced replication-competent Ad serotype 26 (rcAd26) vectors by addi...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Clin Vaccine Immunol
Main Authors: Maxfield, Lori F., Abbink, Peter, Stephenson, Kathryn E., Borducchi, Erica N., Ng'ang'a, David, Kirilova, Marinela M., Paulino, Noelix, Boyd, Michael, Shabram, Paul, Ruan, Qian, Patel, Mayank, Barouch, Dan H.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Microbiology 2015
Assuntos:
Vaccines
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4622110/
https://ncbi.nlm.nih.gov/pubmed/26376928
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/CVI.00510-15
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados